Teva Pays $27M To End Antipsychotic Drug Kickback Claims

Law360, New York (March 11, 2014, 2:35 PM EDT) -- Teva Pharmaceuticals USA Inc. will pay the U.S. Department of Justice and the state of Illinois $27.6 million for allegedly paying a doctor to push prescriptions of a risky antipsychotic drug used to treat schizophrenia to patients, the DOJ announced Tuesday.

The North Wales, Pa.-based drug company and a subsidiary, Ivax LLC, admitted no wrongdoing as part of the deal to settle the government's claims, which included accusations that it provided Illinois physician Dr. Michael J. Reinstein with $50,000 per year and other benefits to prescribe...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.